Financial Year |
March 31 2023 |
Monetary Funds |
4,569,595,868.99 |
Held-for-trading Financial Assets |
248,556,176.00 |
Notes Receivable |
-- |
Accounts Receivable |
523,036,139.16 |
Advances to Suppliers |
44,956,487.75 |
Other Receivables |
7,278,132.41 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
3,064,179,372.22 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
102,530.95 |
Total Current Assets |
8,653,865,122.70 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
14,870,352,265.94 |
Investment Properties |
5,925,210.44 |
Fixed Assetes |
1,182,250,732.65 |
Under-construction Projects |
94,543,096.21 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
173,904,687.02 |
R&D expenses |
-- |
Goodwill |
4,702,868,669.03 |
Long-Term Deferred and Prepaid Expenses |
23,916,327.08 |
Deferred Income Tax Assets |
75,062,244.07 |
Other Non-Current Assets |
1,218,345,321.84 |
Sub-Total of Non-Current Assets |
22,354,391,292.06 |
Total Assets |
31,008,256,414.76 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
1,295,858,161.84 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
59,914,051.33 |
Taxes Payable |
111,711,256.79 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
146,843,411.64 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
1,461,055.23 |
Other Current Liabilities |
34,361.65 |
Sub-Total of Current Liabilities |
1,648,696,040.48 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
5,154,086.50 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
18,110,730.66 |
Total Liabilities |
1,666,806,771.14 |
Paid-In Capital(Or Share Stock) |
6,740,787,907.00 |
Capital Surplus |
14,560,483,871.92 |
Surplus Reserve |
705,533,729.85 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
7,546,229,725.59 |
Minority Stockholder's Interest |
-5,673,117.75 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
29,347,122,761.37 |
Owner's Equity(Stockholder's Equity) |
29,341,449,643.62 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
31,008,256,414.76 |